1. The 10th oligonucleotide therapy approved: golodirsen for duchenne muscular dystrophy;Aartsma-Rus;Nucleic Acid Therapeut.,2020
2. Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy;Alfano;Medicine (Baltim.),2019
3. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle;Bellinger;Nat. Med.,2009
4. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management;Birnkrant;Lancet Neurol.,2018
5. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management;Birnkrant;Lancet Neurol.,2018